Navigation Links
GMO Corn Causes Liver, Kidney Problems in Rats: Study

Environmental group Greenpeace launched a fresh attack on genetically modified maize developed by U.S. biotech giant Monsanto, saying on Tuesday that rats// fed on one version developed liver and kidney problems.

Greenpeace said a study it had commissioned that was published in the journal Archives of Environmental Contamination and Technology showed rats fed for 90 days on Monsanto's MON863 maize showed "signs of toxicity" in the liver and kidneys.

"It is the first time that independent research, published in a peer-reviewed journal, has proved that a GMO authorized for human consumption presents signs of toxicity," Arnaud Apoteker, a spokesman for Greenpeace France said in a statement.

Campaigners against Genetically Modified Organisms (GMO) say that genetic modification technology is unproven and potentially dangerous and that GMO crops can contaminate other crops.

The industry says the technology offers vast potential benefits, poses no health risk and has never been shown to contaminate other crops.

"All the experts agree that the maize in question is as safe as traditional maize," Yann Fichet, director external relations for Monsanto France told France's TF1 television.

He said the maize had been authorized in more than 10 countries and in the European Union but he declined to comment specifically on the allegations raised by Greenpeace.

MON863 is a form of maize genetically modified to make it resistant to corn rootworm. It has been authorized by the European Union for use in animal feed since 2005 and for human consumption since January 2006.

Source-Bio-Bio Technology
'"/>




Page: 1

Related medicine news :

1. Breast Cancer Surgery Causes Psychological problems
2. Causes of weakness in the aged
3. Gene Mutation Causes Ovarian Failure
4. Studying The Causes Of Autism
5. Heart Drug Also Effective In Preventing Specific Causes Of Death
6. More Causes of Bladder Cancer Identified
7. The Causes Of Acid Reflux Questioned
8. Causes of drug induced liver disease
9. Junk Food Causes High Level Of Insulin Resistance In Children
10. Red Color Causes The Allergic Reaction To Strawberries
11. Studies On Hearing Loss Discovers New Causes
Post Your Comments:
(Date:12/5/2009)...mpaign is a collaborative effort by the National A...PM), Midwives Alliance of North America (MANA), Ci...or Traditional Childbearing (ICTC), North American...ucation Accreditation Council (MEAC). To celebrat...ure federal recognition of CPMs language beneficia...
(Date:12/4/2009)...RNewswire/ -- Medithrive, Inc. has won the Patient...SF Bay Area by popular vote conducted by the onlin...months in operation, the SF Bay community has sele...essing medicinal marijuana. ,, The rapid rise...: a dispensary which caters to the consumer, provi...
(Date:12/4/2009)... Mich., Dec. 4 The Editorial Advis...sting Magazine today announced Allergan, Inc. (..." and C.R. Bard, Inc. (NYSE: BCR ) as its Febr...mational and educational use. ,, "The committee...volving its flagship drug Botox and other products...
(Date:12/4/2009)...dy shows that muscle cells grown in the lab can re...rly. The work, performed in dogs and rats, might u... as gastric reflux and fecal incontinence. , Thi...which are the bands of muscle that separate the ma... these areas can cause gastrointestinal esophageal...
(Date:12/4/2009)...ism is a phenomenon that was started by people tha...e of dental work in the US, Canada, and other coun...e, people have found that Mexican Dental Vacation ... , (PRWEB) December 4, 20...s, Mexican Dental Vacation is seeing their best ye...
Breaking Medicine News(10 mins):Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
...linical trials of new drugs developed and would ma...argest potential of patients and diseases. Pharmac...l pharmaceutical companies would invest more than ...al Research and Department of Biotechnology have i...
...Affairs has approved to extend by five years the R...it over five million people.// The extension of...d involve an expenditure of Rs.11.56 billion ($255...t would be the treatment of 5.32 million TB patien...
...d people now a days need to be aware of the variou...xclusive information about //cosmetic surgery and ... The Department of Health says this website will ...ly many people opt for it. Hence there is a need t...
... intellect, according to McMaster University’s res...tudy which also said that there were differences b...shed in the journal Brain also said, said that in ...r right-handers only, indicating that brain asymme...
...s condition are more likely to smoke, and smoking ...asis results in inflammation and scaling of the sk...ack, elbows, knees, palms, face, and the soles of ...ology. Data from as many as 818 psoriasis p...
...at women with Alzheimer’s disease have low levels ...than women with a sound mental health. // The rese...s at the University of Chicago. Previous stu...a common characteristic of the disease. An...
Other Medicine News:Health News:Details of Cosmetic Surgery in a Special Website. 2Health News:Lack Of Estrogen In Brain Tissue Of Women Can Lead To Alzheimer's 2
(Date:12/4/2009)..., , DURHAM, N.C., Dec. 4 /PRNewswire-FirstCal...oard: OXBT) today announced that the first patient...se escalation, clinical trial in Switzerland for u...ry (TBI). Oxycyte is the Company,s perfluorocarbon...al is of invaluable importance in improving the ou...
(Date:12/4/2009)..., , ANNAPOLIS, Md., Dec. 4 /PRNewswire-Firs...biodefense company developing medical countermeasu...nced today the presentation of new data from the C...lyophilized recombinant Protective Antigen (rPA) b...tent after 16 months at various temperatures up to...
(Date:12/4/2009)..., , Opposes use of imported drugs often sto... Dec. 4 Today, the seni...efeat the Dorgan Importation plan encompassed in S..."Senator Dorgan,s importation amendment is poised ...g system to be breached, and our health to be enda...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 1Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 3Thomson Reuters Joins the InChI Trust 13612 1Thomson Reuters Joins the InChI Trust 13612 27 Easy Tips for Healthy Aging 54745 17 Easy Tips for Healthy Aging 54745 2
...et, Inc. (Nasdaq:,MITI), a biopharmaceutical compa...e treatment of cancer, inflammation and autoimmune...1) showing cytotoxic activity of,anti-EpCAM antibo... colon,cancer cells on November 1, 2008 at the 23r...Biological Therapy of Cancer (iSBTc) , taking,plac...
...ionovo, Inc.,(Nasdaq: BNVI ) announced today that...BZL101, will advance to Phase 2 clinical testing a... clinical trial., The Phase 1B clinical trial was...of BZL101 and to determine the safety and feasibil...ment. A total of 27 women with,metastatic breast c...
Other Medicine Technology:Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 2Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 3Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 4Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 5Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4
J Cortex Extrator - Angled Right
J Cannula
J Hydrodissector - Newman
Side Cutting Cystotome
Medicine Products: